|
1
|
Invasive group B streptococcal infections in Finland: a population-based study.
|
Emerg Infect Dis
|
2003
|
1.03
|
|
2
|
Incidence, treatment and outcome of peripartum sepsis.
|
Acta Obstet Gynecol Scand
|
2003
|
0.98
|
|
3
|
Factor H binding as a complement evasion mechanism for an anaerobic pathogen, Fusobacterium necrophorum.
|
J Immunol
|
2008
|
0.97
|
|
4
|
Phospholipase D promotes Arcanobacterium haemolyticum adhesion via lipid raft remodeling and host cell death following bacterial invasion.
|
BMC Microbiol
|
2010
|
0.89
|
|
5
|
Clinical spectrum of bacteraemic Fusobacterium infections: from septic shock to nosocomial bacteraemia.
|
Scand J Infect Dis
|
2011
|
0.84
|
|
6
|
Induction of CD69 expression and Th1 cytokines release from human peripheral blood lymphocytes after in vitro stimulation with Alloiococcus otitidis and three middle ear pathogens.
|
FEMS Immunol Med Microbiol
|
2005
|
0.83
|
|
7
|
Dysgonomonas hofstadii sp. nov., isolated from a human clinical source.
|
Anaerobe
|
2009
|
0.83
|
|
8
|
Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance.
|
J Antimicrob Chemother
|
2004
|
0.82
|
|
9
|
Enzymatic/biochemical analysis of Actinomyces with commercial test kits with an emphasis on newly described species.
|
Anaerobe
|
2005
|
0.79
|
|
10
|
Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus in systemic and nonoral infections in Finland.
|
APMIS
|
2003
|
0.79
|
|
11
|
Evaluation of four commercial test systems for identification of actinomyces and some closely related species.
|
J Clin Microbiol
|
2004
|
0.79
|
|
12
|
[Lack of spleen or spleen malfunction--serious risk factor for sepsis].
|
Duodecim
|
2004
|
0.75
|
|
13
|
[Not Available].
|
Duodecim
|
2007
|
0.75
|
|
14
|
[Cataract surgery and eye drops--is a drop only a habit?].
|
Duodecim
|
2002
|
0.75
|